SCHEMBL6181985

SCHEMBL6181985

CCOC(=O)C(C)(CCCCCC(O)CCCCCC(C)(C(=O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.44
ACACA Q13085 1/20 0.44
PIN1 Q13526 1/20 0.38
MMP8 P22894 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CCR1 P32246 1/20 0.35
TRPA1 O75762 1/20 0.35
POLB P06746 1/20 0.35
PRSS1 P07477 1/20 0.35
CTSG P08311 1/20 0.35
CTRB1 P17538 1/20 0.35
CMA1 P23946 1/20 0.35
CACNA1G O43497 2/20 0.35
ALDH1A1 P00352 2/20 0.34
RECQL P46063 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10264471 0.88 ACACB (0.56) ACACBACACATRPA1KMT2A
SCHEMBL12094471 0.87 ACACB (0.53) ACACBACACALMNATRPA1CHRM2
SCHEMBL6182576 0.86 ACACB (0.50) ACACBACACATRPA1PRSS1CTSG
SCHEMBL6182092 0.86 ACACB (0.50) ACACBACACAPRSS1CTSGCTRB1
SCHEMBL6181498 0.86 ACACB (0.50) ACACBACACAPRSS1CTSGCTRB1
SCHEMBL3283665 0.85 PIN1 (0.40) PIN1MMP8CYP4F2CYP4A11CCR1
SCHEMBL6179995 0.84 ACACB (0.47) ACACBACACALMNATRPA1CHRM2
SCHEMBL6181940 0.84 ACACB (0.42) ACACBACACALMNATDP1TRPA1
SCHEMBL6181978 0.83 ACACB (0.46) ACACBACACATRPA1PRSS1CTSG
SCHEMBL6180359 0.81 ACACB (0.44) ACACBACACATDP1TRPA1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597223-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2005-11-23 EP disclosed
WO-2004067489-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2004-08-12 WO disclosed